Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
1999-2-26
pubmed:abstractText
Nonviral DNA delivery strategies for gene therapy have generally been limited by a lack of specificity and efficacy. However, ligand-mediated endocytosis can specifically deliver DNA in vitro to cells bearing the appropriate cognate receptors. Similarly, in order to circumvent problems related to efficacy, DNA must encode proteins with high intrinsic activities. We show here that the ligand basic fibroblast growth factor (FGF2) can target FGF receptor-bearing cells with DNA encoding therapeutic proteins. Delivery of genes encoding saporin, a highly potent ribosomal inactivating protein, or the conditionally cytotoxic herpes simplex virus thymidine kinase, a protein that can kill cells by activating the prodrug ganciclovir, is demonstrated. The saporin gene was codon optimized for mammalian expression and demonstrated to express functional protein in a cell-free assay. FGF2-mediated delivery of saporin DNA or thymidine kinase DNA followed by ganciclovir treatment resulted in a 60 and 75% decrease in cell number, respectively. Specificity of gene delivery was demonstrated in competition assays with free FGF2 or with recombinant soluble FGF receptor. Alternatively, when histone H1, a ligand that binds to cell surface heparan sulfate proteoglycans ("low-affinity" FGF receptors), was used to deliver DNA encoding thymidine kinase, no ganciclovir sensitivity was observed. These findings establish the feasibility of using ligands such as FGF2 to specifically deliver genes encoding molecular chemotherapeutic agents to cells.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1043-0342
pubmed:author
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
9
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2565-75
pubmed:dateRevised
2008-7-12
pubmed:meshHeading
pubmed-meshheading:9853523-Amino Acid Sequence, pubmed-meshheading:9853523-Animals, pubmed-meshheading:9853523-Base Sequence, pubmed-meshheading:9853523-Binding Sites, pubmed-meshheading:9853523-Cell Line, pubmed-meshheading:9853523-Cell Survival, pubmed-meshheading:9853523-Cell-Free System, pubmed-meshheading:9853523-Cricetinae, pubmed-meshheading:9853523-DNA, pubmed-meshheading:9853523-DNA, Complementary, pubmed-meshheading:9853523-Immunotoxins, pubmed-meshheading:9853523-Molecular Sequence Data, pubmed-meshheading:9853523-N-Glycosyl Hydrolases, pubmed-meshheading:9853523-Plant Proteins, pubmed-meshheading:9853523-Receptors, Fibroblast Growth Factor, pubmed-meshheading:9853523-Ribosome Inactivating Proteins, Type 1, pubmed-meshheading:9853523-Ribosomes, pubmed-meshheading:9853523-Simplexvirus, pubmed-meshheading:9853523-Thymidine Kinase, pubmed-meshheading:9853523-Transfection
pubmed:year
1998
pubmed:articleTitle
Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors.
pubmed:affiliation
Selective Genetics, Inc., San Diego, CA 92121, USA.
pubmed:publicationType
Journal Article